A peptide-based nano-PROTAC synergistically driving ferroptosis-immunotherapy in triple-negative breast cancer
- DOI
- 10.1016/j.apsb.2026.07.045
- Published
- 2026-11
- Container
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.apsb.2026.07.045,
title = {A peptide-based nano-PROTAC synergistically driving ferroptosis-immunotherapy in triple-negative breast cancer},
author = {Jiasha Wu and Rui Ji and Luyi Wang and Yurui Zhu and Shiqin Jian and Yan Zuo and Siyao Liu and Yejiao Shi and Xiaochun Hu and Honggang Hu},
year = {2026},
journal = {Acta Pharmaceutica Sinica B},
doi = {10.1016/j.apsb.2026.07.045},
url = {https://doi.org/10.1016/j.apsb.2026.07.045}
}RIS
TY - JOUR TI - A peptide-based nano-PROTAC synergistically driving ferroptosis-immunotherapy in triple-negative breast cancer AU - Jiasha Wu AU - Rui Ji AU - Luyi Wang AU - Yurui Zhu AU - Shiqin Jian AU - Yan Zuo AU - Siyao Liu AU - Yejiao Shi AU - Xiaochun Hu AU - Honggang Hu PY - 2026 JO - Acta Pharmaceutica Sinica B DO - 10.1016/j.apsb.2026.07.045 UR - https://doi.org/10.1016/j.apsb.2026.07.045 ER -
APA
Wu, J., Ji, R., Wang, L., Zhu, Y., Jian, S., Zuo, Y., Liu, S., Shi, Y., Hu, X., & Hu, H. (2026). A peptide-based nano-PROTAC synergistically driving ferroptosis-immunotherapy in triple-negative breast cancer. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.07.045
Source records
- crossref · retrieved 2026-11-06T09:05:06.575Z